XML 114 R105.htm IDEA: XBRL DOCUMENT v2.4.0.8
Supplemental Guarantor Financial Information (Details 4) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Cash flows from operating activities:      
Net cash provided by (used in) continuing operations $ 348,668 $ 383,262 $ 104,109
Net cash provided by discontinued operations 7,036 6,663 16,334
Net cash provided by operating activities 355,704 389,925 120,443
Cash flows from investing activities:      
Capital expenditures (391,725) (428,731) (272,150)
Proceeds from sale of property, plant and equipment 101,311 35,989 43,042
Cash paid for business acquisition     (3,000)
(Increase) decrease in restricted cash 14 (162) 820
Return of investments in non-consolidated affiliates 19,000 51,707  
Cash invested in non-consolidated affiliates   (224) (471)
Net cash used in continuing operations (271,400) (341,421) (231,759)
Net cash provided by discontinued operations 74,949 135,970 (7,425)
Net cash used in investing activities (196,451) (205,451) (239,184)
Cash flows from financing activities:      
Proceeds from borrowings of long-term debt 2,108,037 1,878,000 1,893,740
Repayments of long-term debt (2,195,750) (2,106,639) (2,036,171)
Payments for debt issuance costs (12,147) (1,011) (8,823)
Payments for settlement of interest rate swaps that include financing element (2,207)    
Net proceeds from the sale of Partnership units   114,530 289,908
Proceeds from stock options exercised 8,321 562 526
Proceeds from stock issued pursuant to our employee stock purchase plan 1,632 1,635 1,887
Purchases of treasury stock (4,539) (2,422) (2,941)
Stock-based compensation excess tax benefit 1,910 1,139 1,034
Distributions to noncontrolling partners in the Partnership (61,959) (57,084) (39,870)
Net cash provided by (used in) financing activities (156,702) (171,290) 99,290
Effect of exchange rate changes on cash and cash equivalents (1,487) (486) (3,007)
Net increase (decrease) in cash and cash equivalents 1,064 12,698 (22,458)
Cash and cash equivalents at beginning of period 34,601 21,903 44,361
Cash and cash equivalents at end of period 35,665 34,601 21,903
Eliminations
     
Cash flows from investing activities:      
Capital expenditures 7,338    
Proceeds from sale of property, plant and equipment (7,338)    
Capital distributions received from consolidated subsidiaries (45,237) (30,782) (30,766)
Investment in consolidated subsidiaries 25,180 27,184 33,713
Return on investment in consolidated subsidiaries     (174,838)
Net cash used in continuing operations (20,057) (3,598) (171,891)
Net cash used in investing activities (20,057) (3,598) (171,891)
Cash flows from financing activities:      
Distributions to noncontrolling partners in the Partnership 45,237 30,782 30,766
Net proceeds from sale of general partner units   (2,426) (1,316)
Capital distributions to affiliates     174,838
Capital contributions received from parent (25,180) (24,758) (32,397)
Net cash provided by (used in) financing activities 20,057 3,598 171,891
Parent | Reportable Legal Entities
     
Cash flows from operating activities:      
Net cash provided by (used in) continuing operations (5,873) (6,877) (1,191)
Net cash provided by operating activities (5,873) (6,877) (1,191)
Cash flows from investing activities:      
Return on investment in consolidated subsidiaries     87,419
Net cash used in continuing operations     87,419
Net cash used in investing activities     87,419
Cash flows from financing activities:      
Proceeds from borrowings of long-term debt 1,102,500 1,164,000 1,336,240
Repayments of long-term debt (1,267,250) (1,422,150) (1,409,644)
Payments for debt issuance costs     (7,666)
Proceeds from stock options exercised 8,321 562 526
Proceeds from stock issued pursuant to our employee stock purchase plan 1,632 1,635 1,887
Purchases of treasury stock (4,539) (2,422) (2,941)
Stock-based compensation excess tax benefit 1,910 1,139 1,034
Borrowings (repayments) between consolidated subsidiaries, net 163,286 264,044 (5,731)
Net cash provided by (used in) financing activities 5,860 6,808 (86,295)
Net increase (decrease) in cash and cash equivalents (13) (69) (67)
Cash and cash equivalents at beginning of period 24 93 160
Cash and cash equivalents at end of period 11 24 93
Guarantor Subsidiaries | Reportable Legal Entities
     
Cash flows from operating activities:      
Net cash provided by (used in) continuing operations 189,563 127,305 62,519
Net cash provided by operating activities 189,563 127,305 62,519
Cash flows from investing activities:      
Capital expenditures (167,632) (205,356) (171,470)
Contract operations acquisition   77,415 62,217
Proceeds from sale of property, plant and equipment 28,274 14,511 13,423
Cash paid for business acquisition     (3,000)
Capital distributions received from consolidated subsidiaries 45,237 30,782 30,766
Investment in consolidated subsidiaries (25,180) (27,184) (33,713)
Net cash used in continuing operations (119,301) (109,832) (101,777)
Net cash used in investing activities (119,301) (109,832) (101,777)
Cash flows from financing activities:      
Net proceeds from the sale of Partnership units     162,236
Capital distributions to affiliates     (87,419)
Borrowings (repayments) between consolidated subsidiaries, net (79,169) (9,822) (34,285)
Net cash provided by (used in) financing activities (79,169) (9,822) 40,532
Net increase (decrease) in cash and cash equivalents (8,907) 7,651 1,274
Cash and cash equivalents at beginning of period 10,461 2,810 1,536
Cash and cash equivalents at end of period 1,554 10,461 2,810
Other Subsidiaries | Reportable Legal Entities
     
Cash flows from operating activities:      
Net cash provided by (used in) continuing operations 164,978 262,834 42,781
Net cash provided by discontinued operations 7,036 6,663 16,334
Net cash provided by operating activities 172,014 269,497 59,115
Cash flows from investing activities:      
Capital expenditures (231,431) (223,375) (100,680)
Contract operations acquisition   (77,415) (62,217)
Proceeds from sale of property, plant and equipment 80,375 21,478 29,619
(Increase) decrease in restricted cash 14 (162) 820
Return of investments in non-consolidated affiliates 19,000 51,707  
Cash invested in non-consolidated affiliates   (224) (471)
Return on investment in consolidated subsidiaries     87,419
Net cash used in continuing operations (132,042) (227,991) (45,510)
Net cash provided by discontinued operations 74,949 135,970 (7,425)
Net cash used in investing activities (57,093) (92,021) (52,935)
Cash flows from financing activities:      
Proceeds from borrowings of long-term debt 1,005,537 714,000 557,500
Repayments of long-term debt (928,500) (684,489) (626,527)
Payments for debt issuance costs (12,147) (1,011) (1,157)
Payments for settlement of interest rate swaps that include financing element (2,207)    
Net proceeds from the sale of Partnership units   114,530 127,672
Distributions to noncontrolling partners in the Partnership (107,196) (87,866) (70,636)
Net proceeds from sale of general partner units   2,426 1,316
Capital distributions to affiliates     (87,419)
Capital contributions received from parent 25,180 24,758 32,397
Borrowings (repayments) between consolidated subsidiaries, net (84,117) (254,222) 40,016
Net cash provided by (used in) financing activities (103,450) (171,874) (26,838)
Effect of exchange rate changes on cash and cash equivalents (1,487) (486) (3,007)
Net increase (decrease) in cash and cash equivalents 9,984 5,116 (23,665)
Cash and cash equivalents at beginning of period 24,116 19,000 42,665
Cash and cash equivalents at end of period $ 34,100 $ 24,116 $ 19,000